Respiratory failure natural history, complications and prognosis: Difference between revisions
No edit summary |
|||
Line 18: | Line 18: | ||
===Natural History=== | ===Natural History=== | ||
*If left untreated, patients with respiratory failure may progress to develop sepsis and multiple organ failure which increases mortality.<ref name="pmid8118729">{{cite journal |vauthors=Weiss SM, Hudson LD |title=Outcome from respiratory failure |journal=Crit Care Clin |volume=10 |issue=1 |pages=197–215 |date=January 1994 |pmid=8118729 |doi= |url=}}</ref> | *If left untreated, patients with respiratory failure may progress to develop sepsis and multiple organ failure which increases mortality.<ref name="pmid8118729">{{cite journal |vauthors=Weiss SM, Hudson LD |title=Outcome from respiratory failure |journal=Crit Care Clin |volume=10 |issue=1 |pages=197–215 |date=January 1994 |pmid=8118729 |doi= |url=}}</ref> | ||
*The symptoms of respiratory failure have a higher incidence and are more severe in patients ≥ 65 years of age.<ref name="pmid11035684">{{cite journal |vauthors=Behrendt CE |title=Acute respiratory failure in the United States: incidence and 31-day survival |journal=Chest |volume=118 |issue=4 |pages=1100–5 |date=October 2000 |pmid=11035684 |doi= |url=}}</ref> | |||
===Complications=== | ===Complications=== |
Revision as of 21:39, 20 March 2018
Respiratory failure Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Respiratory failure natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Respiratory failure natural history, complications and prognosis |
FDA on Respiratory failure natural history, complications and prognosis |
CDC on Respiratory failure natural history, complications and prognosis |
Respiratory failure natural history, complications and prognosis in the news |
Blogs on Respiratory failure natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- If left untreated, patients with respiratory failure may progress to develop sepsis and multiple organ failure which increases mortality.[1]
- The symptoms of respiratory failure have a higher incidence and are more severe in patients ≥ 65 years of age.[2]
Complications
- Pulmonary complications of respiratory failure include:[3]
- Pulmonary emboli
- Barotrauma
- Fibrosis
- Pneumonia
- Extra-pulmonary complications of respiratory failure include:[3]
- Gastrointestinal hemorrhage
- Renal failure
- Infection
- Thrombocytopenia
Prognosis
- The resolution of pulmonary edema and inflammation are important for determining the recovery from lung injury.[4]
- Long term prognosis of patients with respiratory failure depends on the severity of underlying disease.
- Recovery of pulmonary function is variable and determined by the severity of the acute episode.
- Acute respiratory failure has a poor prognosis when there is an underlying hematologic malignancy.
References
- ↑ Weiss SM, Hudson LD (January 1994). "Outcome from respiratory failure". Crit Care Clin. 10 (1): 197–215. PMID 8118729.
- ↑ Behrendt CE (October 2000). "Acute respiratory failure in the United States: incidence and 31-day survival". Chest. 118 (4): 1100–5. PMID 11035684.
- ↑ 3.0 3.1 Pingleton SK (May 1983). "Complications of acute respiratory failure". Med. Clin. North Am. 67 (3): 725–46. PMID 6405105.
- ↑ Matthay MA, Zimmerman GA (October 2005). "Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management". Am. J. Respir. Cell Mol. Biol. 33 (4): 319–27. doi:10.1165/rcmb.F305. PMC 2715340. PMID 16172252.